Ad
DTIL Quote Trading Chart Precision BioSciences Inc.
home / stock / dtil / dtil quote
Quote | Precision BioSciences Inc. (NASDAQ:DTIL)
| Last: | $5.33 |
|---|---|
| Change Percent: | 0.18% |
| Open: | $5.49 |
| Close: | $5.33 |
| High: | $5.6761 |
| Low: | $5.16 |
| Volume: | 69,382 |
| Last Trade Date Time: | 04/25/2025 03:39:40 pm |
Quotes are delayed by 15 to 20 minutes.
DTIL Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $5.33 | $5.49 | $5.33 | $5.6761 | $5.16 | 69,382 | 04-25-2025 |
| $5.5 | $5.61 | $5.5 | $5.685 | $5.41 | 85,405 | 04-24-2025 |
| $5.68 | $5.44 | $5.68 | $5.75 | $5.4 | 187,201 | 04-23-2025 |
| $5.32 | $5.15 | $5.32 | $5.44 | $5.09 | 97,462 | 04-22-2025 |
| $5.13 | $4.95 | $5.13 | $5.245 | $4.95 | 62,249 | 04-21-2025 |
| $5.02 | $5.01 | $5.02 | $5.15 | $4.9 | 99,004 | 04-18-2025 |
| $5.02 | $5.01 | $5.02 | $5.15 | $4.9 | 99,004 | 04-17-2025 |
| $5.01 | $5.42 | $5.01 | $5.505 | $5 | 156,145 | 04-16-2025 |
| $5.52 | $5.2 | $5.52 | $5.73 | $4.73 | 1,056,861 | 04-15-2025 |
| $4.46 | $4.45 | $4.46 | $4.58 | $4.41 | 54,554 | 04-14-2025 |
| $4.4 | $4.25 | $4.4 | $4.4884 | $4.23 | 121,083 | 04-11-2025 |
| $4.23 | $4.5 | $4.23 | $4.635 | $4.1 | 163,708 | 04-10-2025 |
| $4.55 | $4.56 | $4.55 | $4.7383 | $4.425 | 859,458 | 04-09-2025 |
| $4.62 | $4.64 | $4.62 | $4.72 | $4.5129 | 135,948 | 04-08-2025 |
| $4.4 | $4.4 | $4.4 | $4.5 | $4.29 | 207,893 | 04-07-2025 |
| $4.61 | $4.54 | $4.61 | $4.71 | $4.4796 | 178,135 | 04-04-2025 |
| $4.71 | $4.51 | $4.71 | $4.79 | $4.51 | 78,729 | 04-03-2025 |
| $4.69 | $4.42 | $4.69 | $4.83 | $4.42 | 48,088 | 04-02-2025 |
| $4.49 | $4.68 | $4.49 | $4.99 | $4.4 | 126,853 | 04-01-2025 |
| $4.77 | $4.65 | $4.77 | $4.86 | $4.25 | 86,355 | 03-31-2025 |
News, Short Squeeze, Breakout and More Instantly...
Precision BioSciences Inc. Company Name:
DTIL Stock Symbol:
NASDAQ Market:
0.18% G/L:
$5.33 Last:
69,382 Volume:
$5.49 Open:
$5.33 Close:
Precision BioSciences Inc. Website:
Ad
- DTIL - Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies, including gene elimination, gene insertion, and gene excision programs, today announced that management will prese...
-
Nu Ride Inc. - Class A (NRDE) is expected to report for quarter end 2024-12-31 Dalrada Financial Corp. (DFCO) is expected to report for quarter end 2024-12-31 HilleVax Inc. (HLVX) is expected to report $-0.38 for Q4 2024 Chewy Inc. Class A (CHWY) is expected to report $0.03 for Q4 202...
- DTIL - Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene insertion, and gene excision programs, today announced that it will publish financ...